FDA approves Shire's Vyvanse for ADHD

02/24/2007 | MSNBC

Shire PLC says the amphetamine-based drug is meant to supplant its top-selling Adderall XR when that drug goes off patent in 2009. Shire says it believes a new formulation, which makes the drug inactive unless swallowed, will curtail potential abuse of the drug.

View Full Article in:

MSNBC

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Senior Director, Research
America's Health Insurance Plans (AHIP)
Washington, DC
Sr. Principal OptoMechanical Engineer - 14000008M2
Abbott
San Jose, CA
Pharmacy Care Manager
National Association of Chain Drug Stores
Arlington, VA
Regional Director, Southeastern Region - State Affairs
America's Health Insurance Plans (AHIP)
Washington, DC
Sr. Principal Electrical Engineer - 14000008LR
Abbott
San Jose, CA